Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-16

FDA Approved: DEFERASIROX — Original Application (Dr. Reddy's Laboratories Inc)

View source ↗

Summary

FDA approves Dr. Reddy's Laboratories' deferasirox generic under ANDA210945 for the treatment of chronic iron overload due to blood transfusions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deferasirox (Deferasirox)

Snippet

ORIG AP for DEFERASIROX (DEFERASIROX)